KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Receivables (2016 - 2025)

Bausch Health Companies' Receivables history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Receivables rose 9.86% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, up 9.86%, while the annual FY2025 figure was $2.4 billion, 9.86% up from the prior year.
  • Receivables for Q4 2025 was $2.4 billion at Bausch Health Companies, down from $2.4 billion in the prior quarter.
  • Across five years, Receivables topped out at $2.4 billion in Q3 2025 and bottomed at $1.5 billion in Q1 2021.
  • The 5-year median for Receivables is $1.9 billion (2022), against an average of $1.9 billion.
  • The largest annual shift saw Receivables fell 12.44% in 2021 before it grew 21.33% in 2024.
  • A 5-year view of Receivables shows it stood at $1.8 billion in 2021, then grew by 0.85% to $1.8 billion in 2022, then increased by 11.62% to $2.0 billion in 2023, then increased by 7.11% to $2.1 billion in 2024, then increased by 9.86% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Receivables are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.2 billion (Q2 2025).